Increased central angiotensin and osmotic responses in the Ren-2 transgenic rat

Hypertension

Volumn 33, Issue 1 II, 1999, Pages 385-388

  Nishioka, Tatsuya ^a   Callahan, Michael F ^a   Li, Ping ^a   Ferrario, Carlos M ^a   Ganten, Detlev ^b   Morris, Mariana ^c  

^a WAKE FOREST BAPTIST HEALTH   (United States)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Blood pressure; Brain; Genetics; Rats, transgenic; Sodium; Vasopressin

Indexed keywords

ANGIOTENSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; LATERAL BRAIN VENTRICLE; MEAN ARTERIAL PRESSURE; NATRIURESIS; NONHUMAN; OSMOREGULATION; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STIMULUS RESPONSE; TRANSGENIC ANIMAL; VASOPRESSIN RELEASE;

EID: 0032956653     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.33.1.385     Document Type: Article

References (25)

1. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature. 1990;344:541-544.
2. Senanayake P, Moriguchi A, Kumagai H, Ganten D, Ferrario CM, Brosnihan KB. Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides. 1994;15:919-926.
3. Bader M, Zhao Y, Sander M, Lee MA, Bachmann J, Bohm M, Djavidani B, Peters J, Mullins JJ, Ganten D. Role of tissue renin in the pathophysiology of hypertension in TGR(mREN2)27 rats. Hypertension. 1992;19: 681-686.
4. Yang RH, Jin H, Chen SJ, Wyss JM, Oparil S. Blocking hypothalamic ATI receptors lowers blood pressure in salt-sensitive rats. Hypertension. 1992;20:755-762.
5. Phillips MJ. Functions of angiotensin in the central nervous system. Annu Rev Physiol. 1987;49:413-435.
6. Buggy J, Hoffman WE, Phillips MI, Fisher AE, Johnson AK. Osmosensitivity of rat third ventricle and interactions with angiotensm. Am J Physiol. 1979;236:R75-R82.
7. Callahan MF, Li P, Ferrario CM, Ganten D, Morris M. Salt sensitive hypertension in (mRen-2)27 transgenic rats. Hypertension. 1996;27: 573-577.
8. Li P, Morris M, Diz DI, Ferrario CM, Ganten D, Callahan MF. Role of paraventricular angiotensin AT1 receptors in salt-sensitive hypertension in mRen-2 transgenic rats. Am J Physiol. 1996;270: R1178-R1181.
9. Morris M, Li P, Ferrario CM, Ganten D, Callahan MF. Increased responsiveness of vasopressin mRNA to salt loading in mREN-2 transgenic rats. FASEB J. 1997;11:A218. Abstract.
10. Li P, Morris M, Ferrario CM, Barrett C, Ganten D, Callahan MF. Cardiovascular, endocrine and body fluid/electrolyte responses to salt loading in mRen-2 transgenic rats. Am J Physiol. 1998;275: H1130-H1137.
11. Nishioka T, Morris M, Li P, Ganten D, Ferrario CM, Callahan MF. Depressor role of angiotensin AT2 receptors in the (mRen-2)27 transgenic rat. Am J Hypertens. 1998;11:357-362.
12. Schneider K, Gross V, Lippoldt A, Luft F. Exaggerated natriuresis in transgenic (mRen2)27 rats. J Hypertens. 1997;15:1041-1048.
13. Brosnihan BK, Li P, Ganten D, Ferrario CM. Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilation balance of RAS. Am J Physiol. 1997;273:R1908-R1915.
14. Noll G, Lang MG, Tschudi MR, Ganten D, Luscher TF. Endothelial vasoconstrictor prostanoids modulate contractions to acetylcholine and ANG II in Ren-2 rats. Am J Physiol. 1997;272:H493-H500.
15. Moriguchi A, Ferrario CM, Brosnihan KB, Ganten D, Morris M. Differential regulation of central vasopressin in transgenic rats harboring the mouse Ren-2 gene. Am J Physiol. 1994;267:R786-R791.
16. Hohle S, Spitznagel H, Rascher W, Culman J, Unger T. Angiotensin ATI receptor-mediated vasopressin release and drinking are potentiated by an AT2 receptor antagonist. Eur J Pharmacol. 1995;275: 277-282.
17. Reid IA, Schwartz J, Ben L, Maselli J, Keil LC. Interactions between vasopressin and the renin-angiotensin system. Prog Brain Res. 1983;60: 475-491.
18. Bruner CA, Weaver JM, Fink GD. Sodium-dependent hypertension produced by chronic central angiotensin II infusion. Am J Physiol. 1985; 249:H321-H327.
19. Sladek CD, Blair ML, Ramsay DJ. Further studies on the role of angiotensin in the osmotic control of vasopressin release by the organ-cultured rat hypothalamo-neurohypophyseal system. Endocrinology. 1982;111: 599-607.
20. Hogarty DC, Speakman EA, Puig V, Phillips MI. The role of angiotensin AT1 and A2 receptors in the pressor, drinking and vasopressin responses to central angiotensin. Brain Res. 1992;586:289-294.
21. Hogarty DC, Tran DN, Phillips MI. Involvement of angiotensin receptor subtypes in osmotically induced release of vasopressin. Brain Res. 1994; 637:126-132.
22. Hilgers KF, Peters J, Veelken R, Sommer M, Rupprecht G, Ganten D, Luft FC, Mann JF. Increased vascular angiotensin formation in female rats harboring the mouse Ren-2 gene. Hypertension. 1992;19:687-691.
23. Jonklaas J, Buggy J. Angiotensin-estrogen interaction in female brain reduces drinking and pressor responses. Am J Physiol. 1984;247: R167-R172.
24. Johnson AK. The periventricular anteroventral third ventricle (AV3V): its relationship with the subfornical organ and neural systems involved in maintaining body fluid homeostasis. Brain Res Bull. 1985;15:595-601.
25. Meng H, Wielbo D, Gyurko R, Phillips MI. Antisense oligonucleotide to AT1 receptor mRNA inhibits central angiotensin induced thirst and vasopressin. Regul Pept. 1994;54:543-551.